ICD-10 Code M30.2: Juvenile polyarteritis diagnosis and coding guide

Key Takeaways

M30.2 is the billable ICD-10-CM code for juvenile polyarteritis, valid for the 2026 code set.

M30.2 falls under Chapter 13 (Diseases of the musculoskeletal system and connective tissue), block M30-M36.

The parent code M30 is non-billable; always select a specific subcategory such as M30.2 for claim submission.

Pabau’s claims management software supports accurate ICD-10-CM code submission and structured clinical documentation for rheumatology and specialty practices.

ICD-10 Code M30.2 represents juvenile polyarteritis, a form of necrotizing vasculitis that mainly affects small and medium-sized arteries in children. The condition is clinically distinct from adult polyarteritis nodosa (M30.0), even though both share the M30 parent category.

Juvenile polyarteritis causes transmural inflammation of arterial walls, leading to fibrinoid necrosis and potential aneurysm formation. Organ involvement varies but commonly includes the skin, kidneys, peripheral nerves, and musculoskeletal system. Because onset is usually in childhood or adolescence, ICD-10-CM assigns it a separate subcategory from the adult form.

In practice, the presentation can overlap with other pediatric vasculitides, so precise coding is essential. A coder documenting a diagnosis of “polyarteritis” without age specification should query the treating clinician, because the default parent M30 is non-billable.

The AAPC’s ICD-10-CM code lookup confirms M30.2 as the valid, specific, billable juvenile polyarteritis ICD-10 code within the M30 group.

M30 code group: Classification and hierarchy

M30.2 sits within a well-defined hierarchy. In short, understanding the full code group prevents the most common error with this code: using the non-billable parent M30 instead of the correct subcategory.

The block M30-M36 covers systemic connective tissue disorders within Chapter 13 (Diseases of the musculoskeletal system and connective tissue, codes M00-M99). Per the CMS ICD-10 codes page, the National Center for Health Statistics (NCHS) maintains ICD-10-CM for U.S. use, with annual updates effective each October.

M30.2 is unchanged and valid for fiscal year 2026. It has no exact ICD-9 predecessor, though 446.0 serves as the approximate crosswalk for historical records. A coder looking up a polyarteritis nodosa ICD-10 code for an adult patient should land on M30.0, not M30.2.

The same specificity principle applies to neighboring codes in the group, such as M30.8, where documentation must support the specific subtype rather than a vague vasculitis diagnosis.

ICD-10 Code M30.2 billable status and coding rules

M30.2 is a valid, billable ICD-10-CM diagnosis code for fiscal year 2026. For example, it can appear on a claim as a principal or secondary diagnosis code, depending on the clinical context of the encounter. The CDC/NCHS ICD-10-CM web tool confirms its status as an active, specific code with no pending deletions or revisions for 2026.

Several coding rules govern proper use of M30.2. These derive from the ICD-10-CM Official Guidelines for Coding and Reporting, maintained jointly by NCHS and CMS:

• Code to highest specificity: M30 (the parent) is non-billable. Always use M30.2 when the documentation specifies juvenile polyarteritis. Using M30 alone will result in a claim edit or denial.
• No additional fifth digit: M30.2 is a complete, four-character code. No further subdivision exists in ICD-10-CM; it does not require an additional character to be valid.
• Sequencing: When juvenile polyarteritis is the primary reason for the encounter, code it as the principal diagnosis. When it is a comorbidity being monitored alongside another primary condition, sequence it as a secondary code.
• Underlying condition: If the encounter relates to a manifestation caused by juvenile polyarteritis (e.g., renal involvement), code the manifestation first if an official “code first” note exists, then M30.2 as the underlying condition.
• Age of patient: ICD-10-CM does not impose a hard age threshold for M30.2 use, but clinical documentation must support a juvenile onset or presentation. The treating physician’s diagnosis governs code selection.

Using compliance management tools in clinical settings helps practices track coding rule changes across annual ICD-10-CM updates and reduces the risk of submitting non-specific parent codes.

Diagnostic criteria for juvenile polyarteritis

Juvenile polyarteritis does not have a single, widely adopted diagnostic criterion set like the ACR/EULAR criteria used for rheumatoid arthritis. Instead, a juvenile polyarteritis diagnosis is usually clinical, supported by biopsy, angiography, or imaging findings. Understanding the clinical picture helps coders confirm that M30.2 is the right code rather than a related vasculitis code.

Clinical features that support M30.2

• Pediatric or adolescent onset of systemic vasculitis
• Necrotizing inflammation of small to medium arteries confirmed by biopsy or angiography
• Absence of ANCA (antineutrophil cytoplasmic antibodies) positivity – differentiates from ANCA-associated vasculitides
• Systemic symptoms: fever, weight loss, myalgia, arthralgia
• Organ involvement: renal, cutaneous, neurological, or gastrointestinal

Myalgia and arthralgia often persist after the acute vasculitis is brought under control, so many pediatric patients need musculoskeletal rehabilitation well beyond the initial diagnosis. Coordinating that follow-up with a physical therapy practice keeps joint and muscle symptoms from being lost between specialties.

Exclusions to check before coding M30.2

At the M30 category level, the ICD-10-CM tabular carries an Excludes1 note for microscopic polyarteritis (M31.7), so M31.7 is never reported alongside an M30 code. The M30.2 subcategory itself adds no further Type 1 Excludes notes, but several adjacent conditions are clinically excluded by correct diagnosis:

• M30.3 (Kawasaki disease) – if documentation includes mucocutaneous lymph node syndrome features, M30.3 takes precedence over M30.2
• M31.x codes (other necrotizing vasculopathies) – if the pathology report describes granulomatous inflammation (e.g., GPA/Wegener’s), the correct code sits in the M31 range
• M32.x codes (systemic lupus erythematosus) – vasculitis in the context of SLE is coded as a manifestation of M32, not as M30.2

When documentation is ambiguous, query the physician rather than defaulting to M30.2. As a result, accurate structured patient records that capture the physician’s differential-diagnosis reasoning sharply reduce coder queries at the billing stage.

Streamline ICD-10 coding and claims management

Pabau helps rheumatology and specialty practices submit accurate ICD-10-CM codes, maintain structured clinical documentation, and reduce claim denials. See how it works for your practice.

Book a demo

M30.2 vs related codes: Differential coding guidance

The M30 group is compact but clinically varied. Getting the right code depends on reading the physician’s diagnosis closely and understanding what each subcategory captures. Below is a practical differential coding reference for the codes most commonly confused with M30.2, including the Kawasaki disease ICD 10 code (M30.3) and the Churg-Strauss ICD 10 code (M30.1).

Coders handling M31.2 face a similar challenge: matching the documented clinical picture to the most precise code available, rather than defaulting to a broader parent or adjacent code.

Importantly, M30.0 (adult polyarteritis nodosa) and M30.2 (juvenile polyarteritis) are separate billable subcategories, and the distinction rests on the documented clinical picture rather than the patient’s age alone. If a physician documents “polyarteritis nodosa” in a 14-year-old without specifying juvenile form, query before assigning M30.2.

Documentation requirements and coding guidelines for M30.2

Clean claims for M30.2 depend on documentation that specifically names juvenile polyarteritis and ties it to clinical findings. In fact, vague documentation is the most common reason claims with this code face audits or payer queries.

What the clinical record must support

The treating physician’s note, discharge summary, or specialist consultation must contain each of these elements to support M30.2:

• Explicit diagnosis: “Juvenile polyarteritis” stated by the treating physician. Coder-inferred diagnoses are not permitted under ICD-10-CM official guidelines.
• Age or onset context: Documentation that confirms the patient is a minor or that the condition began in childhood or adolescence.
• Supporting clinical evidence: Biopsy findings, angiographic results, laboratory markers, or imaging that corroborate arterial inflammation in a pediatric pattern.
• Differential diagnosis addressed: Notes that distinguish the condition from Kawasaki disease (M30.3) or ANCA-associated vasculitis (M31.x) are particularly useful during audit review.

Practices that use digital clinical documentation tools can build structured note templates that prompt clinicians to include all elements required for high-specificity ICD-10-CM coding. As a result, this reduces the back-and-forth between coders and clinicians at the billing stage.

Prior authorization and insurance implications

Juvenile polyarteritis is a rare diagnosis. For instance, payers may require prior authorization for specialty visits, advanced imaging (MRI angiography, CT angiography), or biologics used in hard-to-treat cases. When submitting a prior authorization request, M30.2 should appear on the request along with supporting laboratory or biopsy documentation.

Some payers apply Local Coverage Determinations (LCDs) or National Coverage Determinations (NCDs) for specific diagnostic tests ordered in the workup of vasculitis. The CMS ICD-10 codes page provides access to coverage policies tied to specific diagnosis codes. Therefore, always cross-reference M30.2 with the relevant LCD before submitting claims for high-cost workup procedures.

For practices managing pediatric rheumatology billing, claims management workflows that flag rare diagnosis codes for secondary review can prevent common submission errors before they reach the payer.

Associated CPT codes for the workup

As a diagnosis code, M30.2 often appears alongside CPT codes for the diagnostic workup and ongoing care of juvenile polyarteritis. Common associated procedures include:

• Laboratory panels for inflammatory markers (e.g., ESR, CRP, ANCA) billed under the appropriate laboratory CPT codes
• Tissue biopsy (e.g., 20200/20205 muscle biopsy codes, or a site-appropriate skin biopsy code such as 11102–11107, depending on the site)
• MRI or CT angiography codes for arterial imaging
• Established office visit E/M codes (99213-99215) for ongoing rheumatology management
• Infusion codes if the patient is on IV immunosuppressive therapy

Pairing M30.2 with medically necessary CPT codes and thorough documentation reduces the risk of medical necessity denials. In addition, practices that follow clinical compliance documentation practices across specialty areas regularly see lower denial rates on rare-disease claims.

The WHO ICD-10 browser provides the international classification context for M30.2, which is useful when treating patients whose prior records use the WHO ICD-10 version rather than the U.S. ICD-10-CM adaptation. The two versions overlap largely at the M30.2 level. However, the ICD-10-CM tabular carries extra U.S.-specific notes and guidelines that the WHO version does not include.

Supporting patient care documentation standards ensures that every encounter note is actionable for both the treating team and the coding and billing staff. In pediatric rheumatology, where the patient group is small and diagnoses are rare, documentation quality directly affects payment outcomes.

The same principle holds for M30.1: the clinical note drives the code, and the code drives the claim. Ambiguity at the documentation level always costs more to resolve after submission than before it.

Conclusion

Juvenile polyarteritis is rare, but the coding errors it generates are common. The most frequent mistakes are:

• Submitting the non-billable parent code M30 instead of M30.2
• Confusing juvenile polyarteritis with Kawasaki disease or adult polyarteritis nodosa
• Missing documentation that forces a post-submission query

Getting M30.2 right comes down to three things: confirm the physician’s documented diagnosis, match the clinical features to the correct subcategory, and back every claim with a complete clinical record.

Pabau’s claims management software helps specialty practices build the documentation workflows and coding review processes that prevent these errors at the source. To see how Pabau supports rheumatology and specialty billing, book a demo with the team.

Continue your research

Coding other Chapter 13 conditions? M15.9 covers polyosteoarthritis, unspecified, including the documentation a clean claim needs.

Need another musculoskeletal code reference? M17.0 breaks down bilateral primary osteoarthritis of the knee and its billing rules.

Looking at less common connective tissue diagnoses? M27.1 covers central giant cell granuloma coding and documentation requirements.

Frequently asked questions